CurifyLabs 🇫🇮
Finnish pharmacy-compounding technology company; Series A co-led by Sandwater and HealthCap to fund scaling, including US expansion.
About CurifyLabs
CurifyLabs provides an automated platform for non-sterile compounding of personalized medicines in pharmacies and hospitals. It combines GMP-manufactured excipient bases, robotics based on 3D-printing methods, in-process quality controls, software, and a formulation library to support standardized preparation and digital documentation.
CurifyLabs is a Finland-based company founded in 2021, now around 47 people. It has raised $14M in disclosed funding. FundFinder classes it as Health & Bio.
Founded by Niklas Sandler (Founder and CTO (Chief Technology Officer); previously Association of Finnish Pharmacies, AstraZeneca; University of Helsinki), Charlotta Topelius (Chief Executive Officer & Founder; repeat founder; previously ABConsulting Oy, BrandBuddy Group; Hanken School of Economics), Mika Kristian Passila (Co-founder, Chief Digital Officer (CDO); repeat founder; previously EG Finland Oy, Leia Media; Tampere University of Applied Sciences).
Its investors also appear on FundFinder's most-active lists for Series A · Healthcare & Wellbeing (54 funds), Series A · Generalist (64 funds), Series A · DeepTech (53 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Series A · $14M · Jul 2026
- HealthCap — HealthCap is a life sciences venture investor and company creator based in Stockholm and founded in 1996.
- Lifeline Ventures — Finland's leading early-stage firm, investing from a €150m fifth fund raised in 2023. · cheques £200k – £3M